GEN Exclusives

More »

GEN News Highlights

More »
Jul 31, 2007

Laureate to Manufacture Enobia Pharma’s Candidate against Hypophosphatasia

  • Laureate Pharma entered into a cGMP contract manufacturing agreement with Enobia Pharma, which is engaged in the development of enzyme replacement therapy for the treatment of hypophosphatasia.

    Laureate will produce Enobia Pharma’s fusion protein for this rare and sometimes fatal metabolic bone disease characterized by skeletal hypomineralization. Enobia anticipates initiating clinical studies in this lead program  in the summer of 2008.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »